Teva Pharmaceutical Industries Ltd (TEVA) stock
TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30113% above fair value
$43.24+0.84 (+1.98%)
Close on Nov 11, 2026Market cap $50.39BP/E 72.1Yield –
Teva Pharmaceutical Industries operating margin
Operating margin is operating income as a percentage of revenue.
Teva Pharmaceutical Industries's operating margin for the twelve months ending Jun 30, 2026 was 11.4%. For fiscal 2025 it was 12.5%, against -1.8% the year before. The highest annual figure on record is 25.5% in fiscal 2007.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.5% | +14.3 |
| FY2024 | Dec 31, 2024 | -1.8% | −4.6 |
| FY2023 | Dec 31, 2023 | 2.7% | +17.5 |
| FY2022 | Dec 31, 2022 | -14.7% | −25.5 |
| FY2021 | Dec 31, 2021 | 10.8% | +32.2 |
| FY2020 | Dec 31, 2020 | -21.4% | −18.8 |
| FY2019 | Dec 31, 2019 | -2.6% | +6.3 |
| FY2018 | Dec 31, 2018 | -9.0% | +71.0 |
| FY2017 | Dec 31, 2017 | -80.0% | −89.8 |
| FY2016 | Dec 31, 2016 | 9.8% | −7.2 |
| FY2015 | Dec 31, 2015 | 17.1% | −2.4 |
| FY2014 | Dec 31, 2014 | 19.5% | +11.4 |
| FY2013 | Dec 31, 2013 | 8.1% | −2.7 |
| FY2012 | Dec 31, 2012 | 10.9% | −6.1 |
| FY2011 | Dec 31, 2011 | 17.0% | −7.0 |
| FY2010 | Dec 31, 2010 | 24.0% | +9.1 |
| FY2009 | Dec 31, 2009 | 14.9% | +4.6 |
| FY2008 | Dec 31, 2008 | 10.3% | −15.1 |
| FY2007 | Dec 31, 2007 | 25.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -5.6% | −16.5 |
| Q1 FY2026 | Mar 31, 2026 | 16.4% | +3.0 |
| Q4 FY2025 | Dec 31, 2025 | 20.0% | +20.7 |
| Q3 FY2025 | Sep 30, 2025 | 19.7% | +20.9 |
| Q2 FY2025 | Jun 30, 2025 | 10.9% | +11.0 |
| Q1 FY2025 | Mar 31, 2025 | 13.3% | +19.0 |
| Q4 FY2024 | Dec 31, 2024 | -0.7% | −17.6 |
| Q3 FY2024 | Sep 30, 2024 | -1.2% | −10.1 |
| Q2 FY2024 | Jun 30, 2024 | -0.1% | +16.7 |
| Q1 FY2024 | Mar 31, 2024 | -5.7% | −5.4 |
| Q4 FY2023 | Dec 31, 2023 | 17.0% | +41.2 |
| Q3 FY2023 | Sep 30, 2023 | 8.9% | −2.9 |
| Q2 FY2023 | Jun 30, 2023 | -16.9% | +8.7 |
| Q1 FY2023 | Mar 31, 2023 | -0.4% | +19.1 |
| Q4 FY2022 | Dec 31, 2022 | -24.2% | −26.1 |
| Q3 FY2022 | Sep 30, 2022 | 11.8% | −4.2 |
| Q2 FY2022 | Jun 30, 2022 | -25.5% | −40.4 |
| Q1 FY2022 | Mar 31, 2022 | -19.5% | −30.4 |
| Q4 FY2021 | Dec 31, 2021 | 1.9% | −7.2 |
| Q3 FY2021 | Sep 30, 2021 | 16.0% | +125.2 |
| Q2 FY2021 | Jun 30, 2021 | 14.9% | +10.4 |
| Q1 FY2021 | Mar 31, 2021 | 10.9% | +6.5 |
| Q4 FY2020 | Dec 31, 2020 | 9.1% | +5.8 |
| Q3 FY2020 | Sep 30, 2020 | -109.2% | −107.2 |
| Q2 FY2020 | Jun 30, 2020 | 4.5% | +19.9 |
| Q1 FY2020 | Mar 31, 2020 | 4.4% | +1.2 |
| Q4 FY2019 | Dec 31, 2019 | 3.3% | +74.9 |
| Q3 FY2019 | Sep 30, 2019 | -2.0% | −2.3 |
| Q2 FY2019 | Jun 30, 2019 | -15.4% | −15.1 |
| Q1 FY2019 | Mar 31, 2019 | 3.2% | −27.8 |
| Q4 FY2018 | Dec 31, 2018 | -71.6% | +169.5 |
| Q3 FY2018 | Sep 30, 2018 | 0.4% | −6.4 |
| Q2 FY2018 | Jun 30, 2018 | -0.3% | +100.0 |
| Q1 FY2018 | Mar 31, 2018 | 31.0% | +15.2 |
| Q4 FY2017 | Dec 31, 2017 | -241.1% | −239.0 |
| Q3 FY2017 | Sep 30, 2017 | 6.7% | −7.0 |
| Q2 FY2017 | Jun 30, 2017 | -100.3% | – |
| Q1 FY2017 | Mar 31, 2017 | 15.8% | – |
| Q4 FY2016 | Dec 31, 2016 | -2.1% | – |
| Q3 FY2016 | Sep 30, 2016 | 13.8% | – |
See a number that looks wrong?